ACC: Bempedoic Acid Cuts Cardiovascular Event Risk in Statin-Intolerant
MONDAY, March 6, 2023 (HealthDay News) — Treatment with bempedoic acid is associated with a lower risk for major adverse cardiovascular events among statin-intolerant patients, according to a study published online March 4 in the New England Journal …
Learn MoreMagnitude of Reduction in PSA Level May Indicate Outcomes in Prostate Cancer
MONDAY, March 6, 2023 (HealthDay News) — Greater depth of prostate-specific antigen (PSA) decline is associated with improved clinical outcomes among men treated with enzalutamide for nonmetastatic castration-resistant prostate cancer, according to a…
Learn MoreThough Often Prescribed, Diuretic Pills May Not Prevent Kidney Stones
MONDAY, March 6, 2023 (HealthDay News) — A new study is raising questions about the effectiveness of medications long used to prevent painful kidney stones, but experts say there’s no reason for patients to toss their prescriptions out at this point….
Learn MoreClinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) — Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are beneficial for treating type 1 diabetes mellitus (T1DM), with similar reductions in glycated h…
Learn MoreNo Consistent Link Found Between β-Blockers, Psychiatric Outcomes
WEDNESDAY, March 1, 2023 (HealthDay News) — There are no consistent links between β-blockers and psychiatric outcomes, according to a study published online Jan. 31 in PLOS Medicine.Yasmina Molero, Ph.D., from the Karolinska Institutet in Stockholm, …
Learn MoreTexas Judge Set to Rule on Abortion Pill
TUESDAY, Feb. 28, 2023 (HealthDay News) — Whether women will continue to be able to get a medication abortion using the drug mifepristone in the United States hinges on the impending ruling of a federal judge in Texas. The case will soon be decided b…
Learn MoreMost U.S. Adults With T2DM Meet Criteria for GLP-RAs, SGLT2is
TUESDAY, Feb. 28, 2023 (HealthDay News) — Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 1…
Learn MoreEight-Week Bedaquiline-Linezolid Noninferior for TB
TUESDAY, Feb. 28, 2023 (HealthDay News) — A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published online Feb. 20 in the New England Journal of Medicine to coincide with …
Learn MoreBlack Patients With Dementia Are Less Likely to Get Appropriate Meds: Study
TUESDAY, Feb. 28, 2023 (HealthDay News) — When Black patients struggle with dementia, they are less likely to receive helpful medications than their white peers, a new study warns.Researchers looked at how often patients received one or more of five …
Learn MoreFeds Will Start Limiting Telehealth Prescriptions for Painkillers, ADHD Drugs
MONDAY, Feb. 27, 2023 (HealthDay News) — Federal officials plan to tighten access to drugs that have the potential for abuse by reinstating federal prescribing requirements that were loosened during the pandemic.The Biden administration will require …
Learn More